iomeprol has been researched along with Cancer of Liver in 35 studies
iomeprol: structure given in first source
iomeprol : A benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and a glycoloyl(methyl)amino group at the 5-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the volumetric iodine-uptake (VIU) changes by dual-energy CT (DECT) in assessing the response to sorafenib treated hepatocellular carcinoma (HCC) patients, compared with AASLD (American Association for the Study of Liver Diseases) and Choi criteria." | 9.17 | Quantitative therapy response assessment by volumetric iodine-uptake measurement: initial experience in patients with advanced hepatocellular carcinoma treated with sorafenib. ( Dai, X; Ganten, MK; Ganten, TM; Höh, K; Schlemmer, HP; Schmidt, B; Xu, K, 2013) |
| "1 and modified RECIST (mRECIST) in patients with unresectable hepatocellular carcinoma (HCC) on sorafenib, and to describe HCC enhancement changes before and after sorafenib treatment." | 7.80 | Hepatocellular carcinoma enhancement on contrast-enhanced CT and MR imaging: response assessment after treatment with sorafenib: preliminary results. ( Agnello, F; Brancatelli, G; Cabibbo, G; Furlan, A; Genco, C; Giannitrapani, L; Lagalla, R; Marin, D; Midiri, M; Salvaggio, G, 2014) |
| "To investigate the volumetric iodine-uptake (VIU) changes by dual-energy CT (DECT) in assessing the response to sorafenib treated hepatocellular carcinoma (HCC) patients, compared with AASLD (American Association for the Study of Liver Diseases) and Choi criteria." | 5.17 | Quantitative therapy response assessment by volumetric iodine-uptake measurement: initial experience in patients with advanced hepatocellular carcinoma treated with sorafenib. ( Dai, X; Ganten, MK; Ganten, TM; Höh, K; Schlemmer, HP; Schmidt, B; Xu, K, 2013) |
| "1 and modified RECIST (mRECIST) in patients with unresectable hepatocellular carcinoma (HCC) on sorafenib, and to describe HCC enhancement changes before and after sorafenib treatment." | 3.80 | Hepatocellular carcinoma enhancement on contrast-enhanced CT and MR imaging: response assessment after treatment with sorafenib: preliminary results. ( Agnello, F; Brancatelli, G; Cabibbo, G; Furlan, A; Genco, C; Giannitrapani, L; Lagalla, R; Marin, D; Midiri, M; Salvaggio, G, 2014) |
| "To define the percentage of small (≤2 cm) hepatocellular carcinoma (HCC) nodules showing the diagnostic enhancement pattern at CEUS, computed tomography (CT), and gadobenate dimeglumine (Gd-BOPTA)-enhanced magnetic resonance (MR) imaging." | 3.79 | Evidence of diagnostic enhancement pattern in hepatocellular carcinoma nodules ≤2 cm according to the AASLD/EASL revised criteria. ( Angileri, R; Cabibbo, B; Cova, MA; De Paoli, L; Pizzolato, R; Quaia, E, 2013) |
| "Spontaneous rupture of hepatocellular carcinoma (HCC) after transcatheter arterial chemoembolization (TACE) is a rare and life-threatening complication." | 1.38 | Spontaneous liver rupture after treatment with drug-eluting beads. ( Goltz, JP; Hahn, D; Kickuth, R; Mottok, A; Ritter, CO; Steger, U; Wartenberg, M, 2012) |
| "C-arm CT helps detection of hepatocellular carcinoma (HCC) during interventional (TACE) treatment." | 1.38 | Diagnostic accuracy of C-arm CT during selective transcatheter angiography for hepatocellular carcinoma: comparison with intravenous contrast-enhanced, biphasic, dynamic MDCT. ( Higashihara, H; Hori, M; Kim, T; Maeda, N; Nakamoto, A; Onishi, H; Osuga, K; Tomiyama, N; Tsuboyama, T, 2012) |
| "In total, 32 patients with colorectal cancer and liver metastases were followed by an average of 2." | 1.36 | Suitability of semi-automated tumor response assessment of liver metastases using a dedicated software package. ( de Greiff, A; Forsting, M; Kalkmann, J; Ladd, SC; Stattaus, J, 2010) |
| "During the arterial phase the residual tumor appeared hyperdense in 97% of the nodules and isodense in 3%, while during the portal phase it was hyperdense in 22%, isodense in 28% and hypodense in 50%, and during the delayed phase hypodense in 100%." | 1.30 | [Multiphasic spiral computed tomography in hepatocarcinoma. An evaluation following different percutaneous ablative procedures]. ( Altei, F; Catalano, O; Cusati, B; Esposito, M; Lobianco, R; Siani, A, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (8.57) | 18.2507 |
| 2000's | 6 (17.14) | 29.6817 |
| 2010's | 26 (74.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rengo, M | 2 |
| Bellini, D | 1 |
| Businaro, R | 1 |
| Caruso, D | 1 |
| Azzara, G | 1 |
| De Santis, D | 1 |
| Picchia, S | 1 |
| Biondi, T | 1 |
| Eid, M | 1 |
| Boschiero, D | 1 |
| Laghi, A | 2 |
| Masada, T | 1 |
| Tanaka, T | 1 |
| Nishiofuku, H | 1 |
| Fukuoka, Y | 1 |
| Sato, T | 1 |
| Tatsumoto, S | 1 |
| Marugami, N | 1 |
| Kichikawa, K | 1 |
| Mulé, S | 1 |
| Pigneur, F | 1 |
| Quelever, R | 1 |
| Tenenhaus, A | 1 |
| Baranes, L | 1 |
| Richard, P | 1 |
| Tacher, V | 1 |
| Herin, E | 1 |
| Pasquier, H | 1 |
| Ronot, M | 1 |
| Rahmouni, A | 1 |
| Vilgrain, V | 1 |
| Luciani, A | 1 |
| García Vicente, AM | 1 |
| Domínguez Ferreras, E | 1 |
| Sánchez Pérez, V | 1 |
| Poblete García, VM | 1 |
| Villa Guzmán, JC | 1 |
| Jiménez Aragón, F | 1 |
| Pineda Pineda, MD | 1 |
| Molino Trinidad, C | 1 |
| Soriano Castrejón, Á | 1 |
| Maffione, AM | 1 |
| Rampin, L | 1 |
| Blickman, JG | 1 |
| Rubello, D | 1 |
| Quaia, E | 1 |
| De Paoli, L | 1 |
| Angileri, R | 1 |
| Pizzolato, R | 1 |
| Cabibbo, B | 1 |
| Cova, MA | 1 |
| Salvaggio, G | 1 |
| Furlan, A | 2 |
| Agnello, F | 1 |
| Cabibbo, G | 1 |
| Marin, D | 1 |
| Giannitrapani, L | 1 |
| Genco, C | 1 |
| Midiri, M | 2 |
| Lagalla, R | 2 |
| Brancatelli, G | 1 |
| Yoon, HJ | 1 |
| Jeon, TY | 1 |
| Yoo, SY | 1 |
| Kim, JH | 1 |
| Eo, H | 1 |
| Lee, SK | 1 |
| Kim, JS | 1 |
| Bartolotta, TV | 1 |
| Taibbi, A | 1 |
| Matranga, D | 1 |
| Lewin, M | 1 |
| Gelu-Simeon, M | 1 |
| Ostos, M | 1 |
| Boufassa, F | 1 |
| Sobesky, R | 1 |
| Teicher, E | 1 |
| Meyer, L | 1 |
| Fontaine, H | 1 |
| Salmon-Céron, D | 1 |
| Samuel, D | 1 |
| Seror, O | 1 |
| Trinchet, JC | 1 |
| Duclos-Vallée, JC | 1 |
| Anzidei, M | 1 |
| Di Martino, M | 1 |
| Sacconi, B | 1 |
| Saba, L | 1 |
| Boni, F | 1 |
| Zaccagna, F | 1 |
| Geiger, D | 1 |
| Kirchin, MA | 1 |
| Napoli, A | 1 |
| Bezzi, M | 1 |
| Catalano, C | 1 |
| Saake, M | 1 |
| Lell, MM | 1 |
| Eller, A | 1 |
| Wuest, W | 1 |
| Heinz, M | 1 |
| Uder, M | 1 |
| Schmid, A | 1 |
| Vetrugno, L | 1 |
| Pompei, L | 1 |
| Zearo, E | 1 |
| Della Rocca, G | 1 |
| Kloeckner, R | 1 |
| Otto, G | 2 |
| Biesterfeld, S | 1 |
| Oberholzer, K | 1 |
| Dueber, C | 1 |
| Pitton, MB | 2 |
| Miyayama, S | 1 |
| Yamashiro, M | 1 |
| Okuda, M | 1 |
| Yoshie, Y | 1 |
| Nakashima, Y | 1 |
| Ikeno, H | 1 |
| Orito, N | 1 |
| Matsui, O | 1 |
| Dudeck, O | 1 |
| Bulla, K | 1 |
| Wieners, G | 1 |
| Ruehl, R | 1 |
| Ulrich, G | 1 |
| Amthauer, H | 1 |
| Ricke, J | 1 |
| Pech, M | 1 |
| Kalkmann, J | 1 |
| Ladd, SC | 1 |
| de Greiff, A | 1 |
| Forsting, M | 1 |
| Stattaus, J | 1 |
| Becker, C | 1 |
| Waggershauser, T | 1 |
| Tiling, R | 1 |
| Weckbach, S | 1 |
| Johnson, T | 1 |
| Meissner, O | 1 |
| Klingenbeck-Regn, K | 1 |
| Reiser, M | 1 |
| Hoffmann, RT | 1 |
| Laghi, F | 1 |
| Catalano, O | 2 |
| Maresca, M | 1 |
| Sandomenico, F | 1 |
| Siani, A | 2 |
| Holzapfel, K | 1 |
| Reiser-Erkan, C | 1 |
| Fingerle, AA | 1 |
| Erkan, M | 1 |
| Eiber, MJ | 1 |
| Rummeny, EJ | 1 |
| Friess, H | 1 |
| Kleeff, J | 1 |
| Gaa, J | 1 |
| De Cecco, CN | 1 |
| Buffa, V | 1 |
| Fedeli, S | 1 |
| Luzietti, M | 1 |
| Vallone, A | 1 |
| Ruopoli, R | 1 |
| Miele, V | 1 |
| Paolantonio, P | 1 |
| Maurizi Enrici, M | 1 |
| David, V | 1 |
| Ritter, CO | 1 |
| Wartenberg, M | 1 |
| Mottok, A | 1 |
| Steger, U | 1 |
| Goltz, JP | 1 |
| Hahn, D | 1 |
| Kickuth, R | 1 |
| Kawamura, Y | 1 |
| Ikeda, K | 1 |
| Seko, Y | 1 |
| Hosaka, T | 1 |
| Kobayashi, M | 1 |
| Saitoh, S | 1 |
| Kumada, H | 1 |
| Higashihara, H | 1 |
| Osuga, K | 1 |
| Onishi, H | 1 |
| Nakamoto, A | 1 |
| Tsuboyama, T | 1 |
| Maeda, N | 1 |
| Hori, M | 1 |
| Kim, T | 2 |
| Tomiyama, N | 1 |
| Koelblinger, C | 1 |
| Schima, W | 1 |
| Berger-Kulemann, V | 1 |
| Wolf, F | 1 |
| Plank, C | 1 |
| Weber, M | 1 |
| Lammer, J | 1 |
| Dai, X | 1 |
| Schlemmer, HP | 1 |
| Schmidt, B | 1 |
| Höh, K | 1 |
| Xu, K | 1 |
| Ganten, TM | 1 |
| Ganten, MK | 1 |
| Krix, M | 1 |
| Kiessling, F | 1 |
| Essig, M | 1 |
| Herth, F | 1 |
| Karcher, A | 1 |
| Le-Huu, M | 1 |
| Kauczor, HU | 1 |
| Delorme, S | 1 |
| Pozzi Mucelli, RM | 1 |
| Como, G | 1 |
| Del Frate, C | 1 |
| Iuri, D | 1 |
| Al-Grhiw, E | 1 |
| Bazzocchi, M | 1 |
| Tatsugami, F | 1 |
| Matsuki, M | 1 |
| Inada, Y | 1 |
| Nakai, G | 1 |
| Tanikake, M | 1 |
| Yoshikawa, S | 1 |
| Narabayashi, I | 1 |
| Herber, SC | 1 |
| Schneider, J | 1 |
| Schuchmann, M | 1 |
| Düber, C | 1 |
| Kummer, I | 1 |
| Manzl, N | 1 |
| Maetani, YS | 1 |
| Isoda, H | 1 |
| Nomura, A | 1 |
| Arizono, S | 1 |
| Hirokawa, Y | 1 |
| Shibata, T | 1 |
| Kaori, T | 1 |
| Murakami, T | 1 |
| Takahashi, S | 1 |
| Tsuda, K | 1 |
| Tomoda, K | 1 |
| Narumi, Y | 1 |
| Oi, H | 1 |
| Nakamura, H | 1 |
| Ishijima, H | 1 |
| Koyama, Y | 1 |
| Aoki, J | 1 |
| Kawano, T | 1 |
| Nakajima, T | 1 |
| Ishizaka, H | 1 |
| Endo, K | 1 |
| Cho, A | 1 |
| Okazumi, S | 1 |
| Takayama, W | 1 |
| Takeda, A | 1 |
| Iwasaki, K | 1 |
| Sasagawa, S | 1 |
| Natsume, T | 1 |
| Kono, T | 1 |
| Kondo, S | 1 |
| Ochiai, T | 1 |
| Ryu, M | 1 |
| Esposito, M | 1 |
| Lobianco, R | 1 |
| Cusati, B | 1 |
| Altei, F | 1 |
1 review available for iomeprol and Cancer of Liver
| Article | Year |
|---|---|
Hepatic tumours in children with biliary atresia: single-centre experience in 13 cases and review of the literature.
Topics: Adolescent; Biliary Atresia; Child; Child, Preschool; Contrast Media; Diagnostic Imaging; Female; Ga | 2014 |
7 trials available for iomeprol and Cancer of Liver
| Article | Year |
|---|---|
MDCT of the liver in obese patients: evaluation of a different method to optimize iodine dose.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Electric Impedance; Female; Humans; Iopamidol; Liver | 2017 |
Response assessment of colorectal liver metastases with contrast enhanced CT/18F-FDG PET.
Topics: Adult; Aged; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Enh | 2013 |
Embolization of the gastroduodenal artery before selective internal radiotherapy: a prospectively randomized trial comparing standard pushable coils with fibered interlock detachable coils.
Topics: Aged; Contrast Media; Duodenum; Embolization, Therapeutic; Equipment Design; Female; Humans; Iopamid | 2011 |
C-arm CT during hepatic arteriography tumour-to-liver contrast: intraindividual comparison of three different contrast media application protocols.
Topics: Angiography; Contrast Media; Female; Humans; Iopamidol; Liver Neoplasms; Male; Middle Aged; Reproduc | 2013 |
Quantitative therapy response assessment by volumetric iodine-uptake measurement: initial experience in patients with advanced hepatocellular carcinoma treated with sorafenib.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocellular; Contrast Media; Female; H | 2013 |
Usefulness of saline pushing in reduction of contrast material dose in abdominal CT: evaluation of time-density curve for the aorta, portal vein and liver.
Topics: Adult; Aged; Aorta, Abdominal; Contrast Media; Drug Administration Schedule; Female; Humans; Iopamid | 2007 |
Effects of injection rates of contrast material on arterial phase hepatic CT.
Topics: Adult; Aged; Aged, 80 and over; Aortography; Contrast Media; Drug Administration Schedule; Female; H | 1998 |
27 other studies available for iomeprol and Cancer of Liver
| Article | Year |
|---|---|
Techniques to Form a Suitable Lipiodol-Epirubicin Emulsion by Using 3-Way Stopcock Methods in Transarterial Chemoembolization for Liver Tumor.
Topics: Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Med | 2017 |
Can dual-energy CT replace perfusion CT for the functional evaluation of advanced hepatocellular carcinoma?
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Iodine; Iopamido | 2018 |
Invited editorial: Response to therapy assessment of colorectal liver metastasis.
Topics: Adult; Aged; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Enh | 2013 |
Evidence of diagnostic enhancement pattern in hepatocellular carcinoma nodules ≤2 cm according to the AASLD/EASL revised criteria.
Topics: Aged; Biopsy; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Female; Humans; Im | 2013 |
Hepatocellular carcinoma enhancement on contrast-enhanced CT and MR imaging: response assessment after treatment with sorafenib: preliminary results.
Topics: Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Iopamidol; Liver Neoplasms; Magneti | 2014 |
3D versus 2D contrast-enhanced sonography in the evaluation of therapeutic response of hepatocellular carcinoma after locoregional therapies: preliminary findings.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Image Interpreta | 2015 |
Imaging Features and Prognosis of Hepatocellular Carcinoma in Patients with Cirrhosis Who Are Coinfected with Human Immunodeficiency Virus and Hepatitis C Virus.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Coinfection; Contrast Media; Diagnostic Imaging; Female; Fra | 2015 |
Evaluation of image quality, radiation dose and diagnostic performance of dual-energy CT datasets in patients with hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Imaging, | 2015 |
Imaging Hepatocellular Carcinoma with Dynamic CT Before and After Transarterial Chemoembolization: Optimal Scan Timing of Arterial Phase.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media; | 2015 |
Could transesophageal echocardiography be useful in selected cases during liver surgery resection?
Topics: Contrast Media; Echocardiography, Transesophageal; Electrocardiography; Female; Hemangioma; Hemodyna | 2016 |
MDCT versus MRI assessment of tumor response after transarterial chemoembolization for the treatment of hepatocellular carcinoma.
Topics: Aged; Antimetabolites, Antineoplastic; Artifacts; Carcinoma, Hepatocellular; Chemoembolization, Ther | 2010 |
Detection of corona enhancement of hypervascular hepatocellular carcinoma by C-arm dual-phase cone-beam CT during hepatic arteriography.
Topics: Aged, 80 and over; Angiography; Carcinoma, Hepatocellular; Cone-Beam Computed Tomography; Contrast M | 2011 |
Suitability of semi-automated tumor response assessment of liver metastases using a dedicated software package.
Topics: Adult; Aged; Antineoplastic Agents; Artificial Intelligence; Colorectal Neoplasms; Contrast Media; D | 2010 |
C-arm computed tomography compared with positron emission tomography/computed tomography for treatment planning before radioembolization.
Topics: Angiography, Digital Subtraction; Contrast Media; Embolization, Therapeutic; Feasibility Studies; Fe | 2011 |
Indeterminate, subcentimetric focal liver lesions in cancer patients: additional role of contrast-enhanced ultrasound.
Topics: Adult; Contrast Media; Cysts; Diagnosis, Differential; Fatty Liver; Female; Follow-Up Studies; Heman | 2010 |
Comparison of diffusion-weighted MR imaging and multidetector-row CT in the detection of liver metastases in patients operated for pancreatic cancer.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Humans | 2011 |
Dual energy CT (DECT) of the liver: conventional versus virtual unenhanced images.
Topics: Contrast Media; Humans; Iopamidol; Liver; Liver Neoplasms; Middle Aged; Radiation Dosage; Radiation | 2010 |
Spontaneous liver rupture after treatment with drug-eluting beads.
Topics: Aged; Angiography; Carcinoma, Hepatocellular; Contrast Media; Doxorubicin; Fatal Outcome; Humans; Io | 2012 |
Heterogeneous type 4 enhancement of hepatocellular carcinoma on dynamic CT is associated with tumor recurrence after radiofrequency ablation.
Topics: Carcinoma, Hepatocellular; Catheter Ablation; Contrast Media; Female; Humans; Iopamidol; Liver Neopl | 2011 |
Diagnostic accuracy of C-arm CT during selective transcatheter angiography for hepatocellular carcinoma: comparison with intravenous contrast-enhanced, biphasic, dynamic MDCT.
Topics: Aged; Aged, 80 and over; Angiography; Carcinoma, Hepatocellular; Catheterization; Contrast Media; Eq | 2012 |
Low mechanical index contrast-enhanced ultrasound better reflects high arterial perfusion of liver metastases than arterial phase computed tomography.
Topics: Contrast Media; Humans; Iohexol; Iopamidol; Liver Neoplasms; Phospholipids; Sulfur Hexafluoride; Tom | 2004 |
Multidetector CT with double arterial phase and high-iodine-concentration contrast agent in the detection of hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Follow-Up Studies | 2006 |
Transarterial chemoembolization in patients not eligible for liver transplantation: single-center results.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoemboliz | 2008 |
CT laparoscopy for detecting small superficial metastatic lesions of the liver surface: initial experience.
Topics: Aged; Contrast Media; Digestive System Neoplasms; Female; Follow-Up Studies; Humans; Iopamidol; Lapa | 2008 |
Use of a combined CT-angiography system for demonstration of correlative anatomy during embolotherapy for hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Angiography; Angiography, Digital Subtraction; Antibiotics, Antineoplastic; | 1999 |
Anatomy of the right anterosuperior area (segment 8) of the liver: evaluation with helical CT during arterial portography.
Topics: Adult; Aged; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Contrast Media; Female; Gallbladder Neo | 2000 |
[Multiphasic spiral computed tomography in hepatocarcinoma. An evaluation following different percutaneous ablative procedures].
Topics: Adult; Aged; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Combined | 1999 |